LXS-196

CAT: 0026-B2092-25Size: 25 mgDry Ice: NoHazardous: No
CAT#:0026-B2092-25Size:25 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
LXS-196 is an orally available protein kinase C (PKC) inhibitor with potential immunosuppressive and antineoplastic activities. Upon oral administration, LXS-196 binds to and inhibits PKC, which prevents the activation of PKC-mediated signaling pathways. This may lead to the induction of cell cycle arrest and apoptosis in susceptible tumor cells.
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months

Related Products

Popular Products